(Reuters) - The U.S. Food and Drug Administration approved Zevra Therapeutics' drug for a rare and fatal genetic disorder, ...

Critics on the FDIC's board include Vice Chair Travis Hill and Democrat Rohit Chopra, who is also the director of the ...

Shares were down 4.3% at 1330 GMT, the lowest since August 8, after the company announced headline results from its trial of ...

U.S. general domestic taxable fixed income funds attracted a robust $2.19 billion in inflows, the highest weekly total since ...